Rongchang Biotech (09995) plans to spend 20 million yuan to 40 million yuan to buy back the company's shares

Zhitong Finance App News, Rongchang Biotech (09995) issued an announcement. Based on confidence in the company's future development and recognition of the company's value, in order to fully stimulate the enthusiasm of the company's employees, continue to establish the company's long-term incentive mechanism, and enhance investors' investment confidence in the company, closely integrate the company's interests, shareholders' interests and employee interests, comprehensively consider the company's stock price situation, business situation, financial situation, etc., and continue to implement the “improve quality, efficiency, and return” action plan. The company plans to buy back the company's shares through centralized bidding transactions. The repurchase shares will be used for employee stock ownership plans or shares at appropriate times in the future. Motivate. If the company fails to use up the repurchased shares within 3 years after the share repurchase implementation results and share change announcements, the unused repurchased shares will be cancelled. If the country adjusts the relevant policies, then this repurchase plan will be implemented in accordance with the adjusted policy.

The share repurchase amount is not less than RMB 20 million (inclusive) and not more than RMB 40 million (inclusive).

The shares repurchased this time are intended to be used for employee stock ownership plans or equity incentives. If the company fails to use up the repurchased shares within 3 years after the implementation results of this share repurchase and the announcement of share changes, the unused repurchased shares will be cancelled. If the country adjusts the relevant policies, then this repurchase plan will be implemented in accordance with the adjusted policy.